Low Dose Naltrexone (LDN)
Low Dose Naltrexone (LDN) represents the newest medical frontier of utilizing well established prescriptions medications in an off-label fashion. Naltrexone is a drug that was originally developed to help opiate abusers block the dangerous effects of narcotic pain medication abuse. Dr. Bihari in New York at Downstate Medical Center, he conducted a research trial to utilize this medication in an extremely low dose fashion for patients diagnosed with HIV/AIDS in 1985 and 1986. He found encouraging results for this particular population of people. As a result of this success, he moved into private practice and began to slowly use this low dose formulation on many other individuals with many other diseases.
Usage of LDN has now expanded into many other domains of medical treatment. Studies are being conducted to investigate the effectiveness of LDN in treating a range of autoimmune illnesses such as hypothyroidism, multiple sclerosis and Cancer as well. LDN has also been gaining acceptance with doctors and patients for the treatment of gastrointestinal diseases such as Crohn’s disease and ulcerative colitis. Some success has also been found using LDN to treat Obesity, PCOS, and a range of social emotional and psychological disorders. LDN is frequently used in conjunction with the traditional prescription medications typical for treating these various conditions.
At the Chicago Health and Wellness Alliance, we take a complete history and physical in order to determine if Low Dose Naltrexone (LDN) treatment is right for you. We work closely with your current specialists to determine an appropriate course of treatment, and ensure that everyone is working together towards your ultimate goal of good health.
For more information on Low Dose Naltrexone Therapy, please visit www.ldners.org,
SERVICES & TREATMENTS
GET IN TOUCH
CHICAGO HEALTH & WELLNESS ALLIANCE
Office of Dr. Alan F. Bain, board-certified internist.